Status:
ACTIVE_NOT_RECRUITING
Assessment of Medherent Medication Management Device and Adherence Platform
Lead Sponsor:
Terrapin Pharmacy
Collaborating Sponsors:
University of Maryland
Conditions:
Mental Health Disorder
Medication Adherence
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study uses a stepped wedge designs to estimate the effect of using the Medherent Medication Management Device on medication adherence for a population of 150 individuals who are diagnosed with se...
Detailed Description
Individuals suffering from Serious Mental Illnesses (SMI) such as schizophrenia, bipolar disorder or depressive disorders are at risk for serious adverse psychiatric, other health, and social outcomes...
Eligibility Criteria
Inclusion
- Currently be a client of a participating community mental health agency
- Have a diagnoses mental illness
- Currently be prescribed a psychotropic medication for the purpose of treatment a mental illness
- Be able to consent to participants in the study
- Be over 18 years old and under 80 years old
Exclusion
- Under 18 years old.
- Over 80 years old.
- Unable to consent to participate in the study.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03775044
Start Date
May 1 2019
End Date
March 31 2023
Last Update
October 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Terrapin Pharmacy
Annapolis, Maryland, United States, 21401